AlloVir, Inc. (NASDAQ:ALVR) gained 11% in pre-open trading Thursday after Gilead Sciences, Inc. (NASDAQ:GILD) disclosed it bought another 2,930,870 common shares in the company's recent public offering at $3.75 per share.
The value of the purchase was nearly $11 million. Gilead owns a total of 16,635,286 common shares following the purchase, representing a nearly 15% stake.
https://www.investing.com/news/stock-market-news/allovir-gains-as-gilead-add-to-stake-432SI-3116627
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.